SCHEMBL2158508

SCHEMBL2158508

COC(=O)c1cccc(C(=O)OC)c1-n1cccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
TSHR P16473 3/20 0.50
LMNA P02545 1/20 0.50
CFTR P13569 1/20 0.48
HSD17B10 Q99714 1/20 0.48
KDM4E B2RXH2 2/20 0.47
POLB P06746 1/20 0.47
ATM Q13315 1/20 0.47
PTPRC P08575 1/20 0.46
MYC P01106 1/20 0.46
KMT2A Q03164 2/20 0.46
MAPT P10636 4/20 0.46
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA9 Q16790 2/20 0.44
CA12 O43570 1/20 0.44
CA7 P43166 1/20 0.44
CA14 Q9ULX7 1/20 0.44
ALOX15 P16050 2/20 0.43
CA5A P35218 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10103507 0.90 HTR7 (0.47) ALDH1A1TSHRLMNACFTRHSD17B10
SCHEMBL16719847 0.88 KMT2A (0.47) ALDH1A1TSHRLMNACFTRHSD17B10
SCHEMBL6747916 0.88 NR4A2 (0.47) ALDH1A1TSHRLMNACFTRHSD17B10
SCHEMBL16719289 0.84 ALDH1A1 (0.42) ALDH1A1TSHRLMNACFTRHSD17B10
SCHEMBL6568367 0.83 TSHR (0.44) ALDH1A1TSHRLMNACFTRHSD17B10
SCHEMBL10110196 0.82 ALDH1A1 (0.41) ALDH1A1TSHRLMNACFTRHSD17B10
SCHEMBL25517666 0.82 ALDH1A1 (0.40) ALDH1A1TSHRLMNACFTRHSD17B10
SCHEMBL26154445 0.81 KMT2A (0.42) ALDH1A1TSHRLMNACFTRHSD17B10
SCHEMBL6571494 0.80 ALDH1A1 (0.48) ALDH1A1LMNACFTRHSD17B10KDM4E
SCHEMBL8876281 0.79 KMT2A (0.62) ALDH1A1TSHRLMNACFTRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178687-B2 Derivatives of pyrroloindole which are inhibitors of Hsp90, compositions containing same, and use thereof SANOFI-AVENTIS (FR) 2012-05-15 US disclosed
US-20110184015-A1 NOVEL DERIVATIVES OF PYRROLOINDOLE WHICH ARE INHIBITORS OF HSP90, COMPOSITIONS CONTAINING SAME, AND USE THEREOF SANOFI-AVENTIS (FR) 2011-07-28 US disclosed
CN-102124008-A Novel pyrroloindole derivatives as Hsp90 inhibitors, compositions containing said derivatives and uses thereof SANOFI AVENTIS 2011-07-13 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110184015-A1 NOVEL DERIVATIVES OF PYRROLOINDOLE WHICH ARE INHIBITORS OF HSP90, COMPOSITIONS CONTAINING SAME, AND USE THEREOF HSP90AB1, HSP90AB2P, HSP90AA1 ALDH1A1 2129/4885TSHR 3561/4885LMNA 3855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.